Dutch experience Improving detection and care In Europe, The Netherlands has proved that a concerted and integrated effort delivers effective detection of families at risk through cascade screening which combined with early treatment significantly improves the prognosis of people with FH. Dr Peter Lansberg, founder and former Director of the Dutch National FH Cascade Screening Programme, discusses the Dutch experience. He emphasises the importance of gaining the active participation of patient advocacy organisations and government.
	Dr Peter Lansberg Department of Vascular Medicine Academic Medical Center Amsterdam

Watch the interview		Listen to the Podcast

In the news PCSK9 inhibitors and new onset diabetes - Reassuring evidence

Reassuring data have been released suggesting that PCSK9 inhibition does not increase the risk of new onset diabetes in statin treated patients.

Read the article by Dr Bertrand Cariou » Plasma PCSK9 levels not associated with metabolic risk

While elevated PCSK9 levels are not associated with increased metabolic risk, an increased ratio of PCSK9/apoB does predispose to higher risk.

Read the article » Safety of LDL-lowering in FH children

One of the questions raised about managing children with familial hypercholesterolaemia (FH, inherited high cholesterol) is the long term safety of cholesterol-lowering treatments. There has been some concern that lowering cholesterol levels could interfere with hormone production and, potentially, future fertility.

Read the article »

Easy access to e-book Understanding PCSK9 inhibition Free for healthcare professionals Prepared by independent experts from PCSK9 Education and Research Forum. Available free to registered members of the Forum. Register and read online »    Download now »

Invite colleagues to listen to the podcasts and read the introductory guide by joining the PCSK9 Forum

Forward to your colleagues now »